Abstract
Novel ruthenium half-sandwich complexes containing (N,O)-bound pyrazolone-based β-ketoamine ligands have been prepared, and the solid-state structures of one ligand and five complexes have been determined by single-crystal X-ray diffraction. Some of the complexes display moderate cytotoxicity toward the human ovarian cancer cell lines A2780 and A2780cisR, the latter line having acquired resistance to cisplatin.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amination
-
Antineoplastic Agents / chemistry*
-
Antineoplastic Agents / pharmacology
-
Cell Line, Tumor
-
Chelating Agents / chemistry
-
Chelating Agents / pharmacology
-
Coordination Complexes / chemistry*
-
Coordination Complexes / pharmacology
-
Crystallography, X-Ray
-
Drug Screening Assays, Antitumor
-
Female
-
Humans
-
Models, Molecular
-
Ovarian Neoplasms / drug therapy
-
Pyrazolones / chemistry*
-
Pyrazolones / pharmacology
-
Ruthenium / chemistry*
-
Ruthenium / pharmacology
Substances
-
Antineoplastic Agents
-
Chelating Agents
-
Coordination Complexes
-
Pyrazolones
-
Ruthenium